Lunai Bioworks (LNAI) Times Interest Earned (2012 - 2026)
Lunai Bioworks (LNAI) posted quarterly Times Interest Earned of -$13.67 for Q1 2026, up 38.03% year-over-year from -$9.91 in Q1 2025, and up 8.89% quarter-over-quarter from -$15.01 in Q4 2025.
Lunai Bioworks (LNAI) Times Interest Earned (2012 - 2026) Analysis & Trends
Lunai Bioworks' Times Interest Earned history runs 15 years deep, the most recent figure standing at -$13.67 for Q1 2026.
- In Q1 2026, Times Interest Earned rose 38.03% year-over-year to -$13.67; the TTM figure through Mar 2026 stood at $828.64 (up 109.67% YoY), while the FY2025 annual figure was -$2.26, down 372.96% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$13.67, up from -$15.01 in the prior quarter.
- The five-year high for Times Interest Earned was $494.48 in Q2 2022, with the low at -$213.29 in Q3 2024.
- The 5-year median for Times Interest Earned is -$33.23 (2023), against an average of -$8.41.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned sank 526.56% in 2024, then jumped 967.17% in 2025.
- Lunai Bioworks' Times Interest Earned stood at -$45.22 in 2022, then soared by 65.66% to -$15.53 in 2023, then slumped by 196.06% to -$45.97 in 2024, then soared by 67.36% to -$15.01 in 2025, then climbed by 8.89% to -$13.67 in 2026.
- Business Quant data shows LNAI's Times Interest Earned at -$13.67 in Q1 2026, -$15.01 in Q4 2025, and -$27.03 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Lunai Bioworks | 6.87 Mn | 3.72 Mn | 20,942.00 | -13.67 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.67 |
| Dec 31, 2025 | -15.01 |
| Sep 30, 2025 | -27.03 |
| Jun 30, 2025 | 247.36 |
| Mar 31, 2025 | -22.06 |
| Dec 31, 2024 | -45.97 |
| Sep 30, 2024 | -213.29 |
| Jun 30, 2024 | 23.18 |
| Mar 31, 2024 | -147.14 |
| Dec 31, 2023 | -15.53 |
| Sep 30, 2023 | -34.04 |
| Jun 30, 2023 | -178.13 |
| Mar 31, 2023 | -33.23 |
| Dec 31, 2022 | -45.22 |
| Sep 30, 2022 | -75.23 |
| Jun 30, 2022 | 494.48 |
| Mar 31, 2022 | -42.38 |
| Dec 31, 2021 | -67.79 |
| Sep 30, 2021 | -83.63 |
| Jun 30, 2021 | 73.54 |